Teladoc Health Inc (TDOC)
12.99
-0.19
(-1.44%)
USD |
NYSE |
Apr 19, 16:00
13.03
+0.04
(+0.31%)
After-Hours: 20:00
Teladoc Health Cash from Financing (TTM): 10.85M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 10.85M |
September 30, 2023 | 17.01M |
June 30, 2023 | 12.58M |
March 31, 2023 | 7.034M |
December 31, 2022 | 6.497M |
September 30, 2022 | 8.741M |
June 30, 2022 | 8.891M |
March 31, 2022 | 21.59M |
December 31, 2021 | 40.95M |
September 30, 2021 | 104.76M |
June 30, 2021 | 104.40M |
March 31, 2021 | 866.26M |
December 31, 2020 | 859.14M |
September 30, 2020 | 798.74M |
June 30, 2020 | 807.47M |
March 31, 2020 | 39.44M |
December 31, 2019 | 35.09M |
September 30, 2019 | 32.50M |
June 30, 2019 | 364.70M |
Date | Value |
---|---|
March 31, 2019 | 644.12M |
December 31, 2018 | 645.61M |
September 30, 2018 | 596.70M |
June 30, 2018 | 380.75M |
March 31, 2018 | 364.20M |
December 31, 2017 | 475.43M |
September 30, 2017 | 516.70M |
June 30, 2017 | 406.64M |
March 31, 2017 | 143.87M |
December 31, 2016 | 20.68M |
September 30, 2016 | 20.41M |
June 30, 2016 | 165.10M |
March 31, 2016 | 164.22M |
December 31, 2015 | 164.01M |
September 30, 2015 | 164.21M |
June 30, 2015 | 57.31M |
March 31, 2015 | 69.80M |
December 31, 2014 | 70.16M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
6.497M
Minimum
Dec 2022
866.26M
Maximum
Mar 2021
218.24M
Average
35.09M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Omnicell Inc | 23.42M |
Phreesia Inc | -17.12M |
10x Genomics Inc | 13.67M |
Biote Corp | -14.38M |
American Shared Hospital Services | 1.91M |